Radiation dosimetry and pharmacokinetics of florbetapir (18F) in Japanese subjects

被引：0
作者：
Masako Nakano
Tomomi Nakamura
Yasushi Takita
Kazunori Uenaka
Tomoaki Ando
Michio Senda
Abhinay D. Joshi
Ming Lu
Christopher Breault
Michael J. Pontecorvo
机构：
[1] Eli Lilly Japan K.K.,
[2] Division of Molecular Imaging,undefined
[3] Institute of Biomedical Research and Innovation,undefined
[4] Avid Radiopharmaceuticals,undefined
来源：
Annals of Nuclear Medicine | 2019年 / 33卷
关键词：
β-Amyloid; Brain PET; Whole-body biodistribution; Dosimetry; Japan;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：639 / 645
页数：6
相关论文
共 23 条
[1]  
Wong DF(2010)In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18) J Nucl Med 51 913-920
[2]  
Rosenberg PB(2014)Radiation dosimetry of florbetapir F 18 EJNMMI Res 4 4-1894
[3]  
Zhou Y(2009)Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain J Nucl Med 50 1887-310
[4]  
Kumar A(2003)Physical models and dose factors for use in internal dose assessment Health Phys 85 294-1027
[5]  
Raymont V(2005)OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine J Nucl Med 46 1023-undefined
[6]  
Ravert HT(undefined)undefined undefined undefined undefined-undefined
[7]  
Joshi AD(undefined)undefined undefined undefined undefined-undefined
[8]  
Pontecorvo MJ(undefined)undefined undefined undefined undefined-undefined
[9]  
Adler L(undefined)undefined undefined undefined undefined-undefined
[10]  
Stabin MG(undefined)undefined undefined undefined undefined-undefined
123